Radicle Science

Open Book Extracts, announced the launch of its third trial on rare cannabinoids, in partnership with Radicle Science. Radicle Science is conducting the four-week blinded, randomized, placebo-controlled, institutional review board approved trial comparing the effects of various OBX cannabinoid...

Purissima, announced the official commercialization and sample availability of their cannabichromene (CBC) in partnership with Open Book Extracts. This launch follows the unveiling of Purissima's exclusive, multi-year processing and distribution partnership with OBX that was announced in July....

Radicle Science, an AI-driven healthtech B-corp revealed the results of cannabinoid clinical trial on pain, in partnership with Open Book Extracts (OBX). All formulations in the pain study on CBD and rare cannabinoids were supplied by OBX, a NSF-certified manufacturer and distributor of cannabinoid...

Open Book Extracts completed its first randomized, controlled trial on rare cannabinoids, with the support of Radicle Science. Radicle Science conducted a Radicle Discovery study on several OBX formulations. The study was a four-week blinded, randomized, controlled, parallel group comparison of the...

Radicle Science will launch large-scale, blinded, placebo-controlled clinical trials on rare cannabinoids including THCV, CBN, CBG, and CBC, to study their effects on energy, focus, appetite, sleep disturbance, pain, stress, and anxiety. These unprecedented Radicle Discovery studies will involve...